BridgeBio 製藥公司 - 收益表 (TTM)

BridgeBio 製藥公司
DE ˙ MUN ˙ US10806X1028
€56.19 ↓ -1.02 (-1.78%)
2026-06-01
分享價格
收益表 (TTM)

BridgeBio 製藥公司收益表顯示了一段時間內收入和支出的變化。收益表的數據包括銷售和收入、毛利、研發開支(R&D)、銷售、一般及行政開支(SG&A)、營業利潤、所得稅開支、財務成本、非營業收益、每股盈利(EPS)和已發行股份。

除以每股為單位的數字外,所有數字為1,000,000倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
收入 63 57 70 71 91 89 78 78 6 9 9 219 219 218 222 127 236 354 502 580
改變 (%) -9.22 22.41 1.77 27.80 -2.21 -12.42 0.17 -92.70 66.13 -1.33 2,249.75 0.24 -0.62 1.90 -42.58 85.07 50.03 41.92 15.51
佔收入的百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
銷售成本 0 2 3 4 5 4 3 3 3 2 2 2 2 2 4 6 9 15 21 28
改變 (%) 1,333.94 99.23 43.29 13.25 -14.15 -20.84 -20.30 -3.69 -5.35 -1.96 -2.17 -0.04 0.00 62.12 52.63 51.61 66.47 40.32 34.82
佔收入的百分比 0.17 2.74 4.47 6.29 5.57 4.89 4.42 3.52 46.45 26.46 26.29 1.09 1.09 1.10 1.75 4.65 3.81 4.22 4.18 4.87
營業毛利 63 55 67 66 86 84 74 75 3 7 7 216 217 215 218 121 227 339 481 552
改變 (%) -11.56 20.24 -0.17 28.77 -1.51 -11.99 1.12 -95.95 128.13 -1.10 3,053.04 0.24 -0.63 1.23 -44.27 86.70 49.38 41.99 14.67
佔收入的百分比 99.83 97.26 95.53 93.71 94.43 95.11 95.58 96.48 53.55 73.54 73.71 98.91 98.91 98.90 98.25 95.35 96.19 95.78 95.82 95.13
銷售、一般及行政費用 162 172 189 191 181 166 143 131 130 135 151 185 209 242 289 329 383 451 531 589
改變 (%) 6.23 10.09 0.85 -5.01 -8.23 -13.78 -8.80 -0.23 3.52 11.66 23.04 12.63 15.83 19.53 14.04 16.13 17.98 17.68 10.83
佔收入的百分比 257.48 301.30 270.97 268.53 199.59 187.31 184.41 167.89 2,295.68 1,430.52 1,618.73 84.76 95.24 111.01 130.21 258.60 162.26 127.60 105.81 101.52
研發 407 419 451 436 443 431 399 385 384 416 456 504 511 506 506 477 473 466 452 467
改變 (%) 3.01 7.64 -3.31 1.48 -2.66 -7.27 -3.70 -0.24 8.50 9.44 10.56 1.43 -0.92 0.02 -5.83 -0.73 -1.60 -2.99 3.36
佔收入的百分比 648.35 735.70 646.94 614.70 488.09 485.83 514.45 494.57 6,762.33 4,416.49 4,898.54 230.48 233.21 232.52 228.24 374.30 200.78 131.69 90.02 80.55
營運支出 568 592 643 631 629 601 546 518 517 554 609 692 722 750 799 812 865 932 1,004 1,084
改變 (%) 4.18 8.59 -1.86 -0.40 -4.36 -9.16 -5.14 -0.25 7.18 9.93 13.59 4.43 3.93 6.50 1.63 6.49 7.77 7.71 7.97
佔收入的百分比 906.00 1,039.75 922.38 889.51 693.26 678.04 703.28 665.97 9,104.46 5,873.47 6,543.56 316.34 329.54 344.62 360.19 637.55 366.84 263.51 200.00 186.94
營業收入 -506 -535 -573 -560 -538 -513 -468 -440 -511 -544 -599 -473 -503 -533 -577 -685 -629 -578 -502 -504
改變 (%) 5.85 7.12 -2.30 -3.97 -4.72 -8.60 -6.02 16.08 6.52 10.13 -21.11 6.36 5.91 8.39 18.63 -8.13 -8.07 -13.21 0.43
佔收入的百分比 -806.00 -939.75 -822.38 -789.51 -593.26 -578.04 -603.28 -565.97 -9,004.46 -5,773.47 -6,443.56 -216.34 -229.54 -244.62 -260.19 -537.55 -266.84 -163.51 -100.00 -86.94
利息花費 -42 -43 -47 -57 -67 -76 -80 -80 -81 -81 -81 -85 -87 -90 -99 -118 -133 -158 -178 -189
改變 (%) 0.32 9.79 22.67 16.45 13.11 6.42 -0.28 0.39 0.60 0.34 4.12 2.77 3.17 10.65 18.80 12.46 18.91 12.99 5.99
佔收入的百分比 -67.69 -74.81 -67.10 -80.88 -73.70 -85.25 -103.59 -103.13 -1,419.03 -859.26 -873.79 -38.72 -39.70 -41.21 -44.74 -92.58 -56.26 -44.59 -35.50 -32.57
淨利 -495 -535 -563 -596 -509 -491 -481 -425 -573 -613 -643 -538 -454 -439 -536 -668 -776 -797 -725 -722
改變 (%) 8.09 5.08 5.92 -14.52 -3.65 -1.95 -11.69 34.84 6.92 4.99 -16.32 -15.69 -3.30 22.08 24.68 16.24 2.67 -9.06 -0.47
佔收入的百分比 -789.46 -939.99 -806.90 -839.85 -561.78 -553.52 -619.70 -546.34 -10,096.65 -6,498.14 -6,913.92 -246.23 -207.11 -201.53 -241.44 -524.25 -329.25 -225.31 -144.39 -124.41

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:BBIO US$67.33
IT:1BBIO €54.64
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista